149 related articles for article (PubMed ID: 27864930)
21. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis.
Weidinger S; Rodríguez E; Stahl C; Wagenpfeil S; Klopp N; Illig T; Novak N
J Invest Dermatol; 2007 Mar; 127(3):724-6. PubMed ID: 17096018
[No Abstract] [Full Text] [Related]
22. Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis.
Zhang H; Guo Y; Wang W; Shi M; Chen X; Yao Z
Allergy; 2011 Mar; 66(3):420-7. PubMed ID: 21039602
[TBL] [Abstract][Full Text] [Related]
23. Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis.
Stemmler S; Parwez Q; Petrasch-Parwez E; Epplen JT; Hoffjan S
J Invest Dermatol; 2007 Mar; 127(3):722-4. PubMed ID: 17008875
[No Abstract] [Full Text] [Related]
24. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany.
Ruether A; Stoll M; Schwarz T; Schreiber S; Fölster-Holst R
Br J Dermatol; 2006 Nov; 155(5):1093-4. PubMed ID: 17034559
[No Abstract] [Full Text] [Related]
25. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
Hughes R; Collins P; Rogers S
Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
[TBL] [Abstract][Full Text] [Related]
26. Association analysis of filaggrin gene mutations and atopic dermatitis in Northern China.
Ma L; Zhang L; Di ZH; Zhao LP; Lu YN; Xu J; Chen HD; Gao XH
Br J Dermatol; 2010 Jan; 162(1):225-7. PubMed ID: 19863505
[No Abstract] [Full Text] [Related]
27. Filaggrin gene loss-of-function mutations explain discordance of atopic dermatitis within dizygotic twin pairs.
Thomsen SF; Elmose C; Szecsi PB; Stender S; Kyvik KO; Backer V; Thyssen JP
Int J Dermatol; 2016 Dec; 55(12):1341-1344. PubMed ID: 27653621
[TBL] [Abstract][Full Text] [Related]
28. Filaggrin mutations as an archetype for understanding the pathophysiology of atopic dermatitis.
Banks TA; Gada SM
J Am Acad Dermatol; 2014 Sep; 71(3):592-3. PubMed ID: 25128113
[No Abstract] [Full Text] [Related]
29. Health-related quality of life in adult dermatitis patients stratified by filaggrin genotype.
Heede NG; Thyssen JP; Thuesen BH; Linneberg A; Szecsi PB; Stender S; Johansen JD
Contact Dermatitis; 2017 Mar; 76(3):167-177. PubMed ID: 27995642
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of severe atopic dermatitis with methotrexate.
Balasubramaniam P; Ilchyshyn A
Clin Exp Dermatol; 2005 Jul; 30(4):436-7. PubMed ID: 15953091
[No Abstract] [Full Text] [Related]
31. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Garritsen FM; Roekevisch E; van der Schaft J; Deinum J; Spuls PI; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497
[TBL] [Abstract][Full Text] [Related]
32. Filaggrin mutations confer susceptibility to atopic dermatitis but not to asthma.
Rogers AJ; Celedón JC; Lasky-Su JA; Weiss ST; Raby BA
J Allergy Clin Immunol; 2007 Dec; 120(6):1332-7. PubMed ID: 18073125
[TBL] [Abstract][Full Text] [Related]
33. Information about filaggrin genotype is valuable for adult atopic dermatitis patients.
Fransen M; Mohammadzadeh P; Bandier J; Overgaard LE; Johansen JD; Thyssen JP
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):e156-e158. PubMed ID: 27520506
[No Abstract] [Full Text] [Related]
34. Carriers of filaggrin gene (FLG) mutations avoid professional exposure to irritants in adulthood.
Bandier J; Ross-Hansen K; Carlsen BC; Menné T; Linneberg A; Stender S; Szecsi PB; Meldgaard M; Thyssen JP; Johansen JD
Contact Dermatitis; 2013 Dec; 69(6):355-62. PubMed ID: 23808934
[TBL] [Abstract][Full Text] [Related]
35. [FILAGGRIN GENE NULL-MUTATIONS AND ATOPIC DISEASES].
Pipinić IS; Macan J
Acta Med Croatica; 2015; 69(5):467-73. PubMed ID: 29087092
[TBL] [Abstract][Full Text] [Related]
36. Retrospective review of the use of azathioprine in severe atopic dermatitis.
Lear JT; English JS; Jones P; Smith AG
J Am Acad Dermatol; 1996 Oct; 35(4):642-3. PubMed ID: 8859304
[No Abstract] [Full Text] [Related]
37. Increased compound heterozygous filaggrin mutations in severe atopic dermatitis in the United States.
Mohiuddin MS; Ramamoorthy P; Reynolds PR; Curran-Everett D; Leung DY
J Allergy Clin Immunol Pract; 2013; 1(5):534-6. PubMed ID: 24565632
[No Abstract] [Full Text] [Related]
38. Individuals who are homozygous for the 2282del4 and R501X filaggrin null mutations do not always develop dermatitis and complete long-term remission is possible.
Thyssen JP; Carlsen BC; Bisgaard H; Giwercman C; Johansen JD; Linneberg A; Meldgaard M; Szecsi PB; Stender S; Menné T
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):386-9. PubMed ID: 21501248
[TBL] [Abstract][Full Text] [Related]
39. Skin barrier function in atopic dermatitis.
Vickery BP
Curr Opin Pediatr; 2007 Feb; 19(1):89-93. PubMed ID: 17224668
[TBL] [Abstract][Full Text] [Related]
40. Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
Garritsen FM; van den Heuvel JM; Bruijnzeel-Koomen CAFM; Maitland-van der Zee AH; van den Broek MPH; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1336-1342. PubMed ID: 29485224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
